• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析智能诊断方法辅助治疗 COPD 急性加重期患者。

Analyzing the Treatment of Patients with Acute Exacerbation of COPD with the Aid of Intelligent Diagnosis Method.

机构信息

The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250001, China.

Maternal and Child Health Care Hospital of Dongchangfu District, Liaocheng City Shandong Province, Liaocheng 252000, China.

出版信息

J Healthc Eng. 2022 Mar 12;2022:3962074. doi: 10.1155/2022/3962074. eCollection 2022.

DOI:10.1155/2022/3962074
PMID:35313509
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8934218/
Abstract

To observe the clinical efficacy of heat clearing phlegm mixture combined with vibration sputum excretion instrument in the treatment of patients with acute exacerbation of COPD with phlegm-heat obstructing lung, 90 patients with acute exacerbation of COPD are selected and divided into three groups, namely, control group, traditional medicine group, and combined group: the control group (conventional western medicine treatment), traditional medicine group (heat clearing and phlegm mixture), and combined group (heat clearing and phlegm mixture + vibratory sputum excretion instrument) with 30 cases each. All the patients in the three groups were given conventional western medicine treatment. On this basis, the traditional medicine group was given the oral administration of the heat-clearing and phlegm-clearing mixture, and the combined group was given the oral administration of the heat-clearing and phlegm-clearing mixture and the vibratory sputum discharge apparatus. Machine learning is used to classify the patients into three groups based on the characteristics of their biomarkers, physical attributes, and medical history. The TCM syndrome score, blood gas analysis, lung function, and inflammatory indexes of the three groups were compared. TCM syndrome scores of the three groups were all lower than before; both the combined group and the TCM group were better than the control group ( < 0.05). Although the improvement degree of the combined group was better than that of the TCM group, the difference was not statistically significant ( > 0.05). TCM syndrome effect is seen to be 96.55% in the combined group, 89.29% in the TCM group, and 63.33% in the control group. Blood gas analysis is also performed; PO2 and PCO2 of the three groups were significantly improved after treatment. The combination group was superior to the traditional medicine group and the control group ( < 0.05), and the traditional medicine group was superior to the control group ( < 0.05). It is concluded that the combination of heat clearing phlegm mixture and vibration sputum excretion instrument can improve TCM syndrome score, CAT score, blood gas analysis, lung function, and inflammatory indicators in patients with acute exacerbation of COPD with phlegm-heat obstructing lung.

摘要

观察清热化痰合剂联合振动排痰仪治疗痰热壅肺型 COPD 急性加重期的临床疗效,选择急性加重期 COPD 患者 90 例,分为三组,即对照组、中药组、联合组:对照组(常规西药治疗)、中药组(清热化痰合剂)和联合组(清热化痰合剂+振动排痰仪),每组 30 例。三组患者均给予常规西药治疗。在此基础上,中药组给予清热化痰合剂口服,联合组给予清热化痰合剂口服和振动排痰仪治疗。采用机器学习根据患者的生物标志物、身体属性和病史将患者分为三组。比较三组患者的 TCM 证候评分、血气分析、肺功能和炎症指标。三组 TCM 证候评分均低于治疗前;联合组和中药组均优于对照组(<0.05)。虽然联合组的改善程度优于中药组,但差异无统计学意义(>0.05)。联合组 TCM 证候疗效为 96.55%,中药组为 89.29%,对照组为 63.33%。血气分析也有改善;三组治疗后 PO2 和 PCO2 均明显改善。联合组优于中药组和对照组(<0.05),中药组优于对照组(<0.05)。结论清热化痰合剂联合振动排痰仪可改善痰热壅肺型 COPD 急性加重期患者的 TCM 证候评分、CAT 评分、血气分析、肺功能和炎症指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a4/8934218/df039b8640cf/JHE2022-3962074.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a4/8934218/df039b8640cf/JHE2022-3962074.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a4/8934218/df039b8640cf/JHE2022-3962074.001.jpg

相似文献

1
Analyzing the Treatment of Patients with Acute Exacerbation of COPD with the Aid of Intelligent Diagnosis Method.分析智能诊断方法辅助治疗 COPD 急性加重期患者。
J Healthc Eng. 2022 Mar 12;2022:3962074. doi: 10.1155/2022/3962074. eCollection 2022.
2
Clearing heat and resolving phlegm for acute exacerbation of chronic obstructive pulmonary disease with the syndrome of phlegm-heat obstruction of the lung.清热化痰法治疗痰热壅肺型慢性阻塞性肺疾病急性加重期。
J Int Med Res. 2020 Aug;48(8):300060520945502. doi: 10.1177/0300060520945502.
3
[Therapy for clearing heat and resolving phlegm in treatment of systemic inflammatory response syndrome in acute deterioration stage of chronic obstructive pulmonary disease: a randomized controlled trial].清热化痰法治疗慢性阻塞性肺疾病急性加重期全身炎症反应综合征的随机对照试验
Zhong Xi Yi Jie He Xue Bao. 2009 Feb;7(2):105-9. doi: 10.3736/jcim20090202.
4
Comparative effectiveness of phlegm-heat clearing Chinese medicine injections for AECOPD: A systematic review and network meta-analysis.痰热清注射液治疗 AECOPD 的疗效比较:系统评价和网络荟萃分析。
J Ethnopharmacol. 2022 Jun 28;292:115043. doi: 10.1016/j.jep.2022.115043. Epub 2022 Feb 4.
5
[Warm acupuncture on chronic obstructive pulmonary disease with phlegm-turbid obstructing of the lung: a randomized controlled trial].温针灸治疗慢性阻塞性肺疾病痰浊阻肺证的随机对照试验
Zhongguo Zhen Jiu. 2019 Sep 12;39(9):918-22. doi: 10.13703/j.0255-2930.2019.09.002.
6
Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial.宣白承气汤作为慢性阻塞性肺疾病急性加重期痰热壅肺证的辅助治疗:一项多中心、随机、双盲、安慰剂对照临床试验
BMC Complement Altern Med. 2014 Jul 11;14:239. doi: 10.1186/1472-6882-14-239.
7
The efficacy and safety of combined traditional Chinese and western medicine in the treatment of chronic obstructive pulmonary disease complicated with respiratory failure: a systematic review and meta-analysis study.中药联合西药治疗慢性阻塞性肺疾病合并呼吸衰竭的疗效及安全性:系统评价和荟萃分析研究。
Ann Palliat Med. 2022 Mar;11(3):1102-1111. doi: 10.21037/apm-22-272.
8
[Analysis of medication regularity of classical prescription in treatment of COPD based on multi-target efficacy evaluation system of Chinese medicine].基于中医多靶点效应评价体系分析经典方剂治疗慢性阻塞性肺疾病的用药规律
Zhongguo Zhong Yao Za Zhi. 2021 Nov;46(21):5710-5718. doi: 10.19540/j.cnki.cjcmm.20210729.401.
9
Effect of Tanreqing Injection on treatment of acute exacerbation of chronic obstructive pulmonary disease with Chinese medicine syndrome of retention of phlegm and heat in Fei.痰热清注射液治疗肺热痰壅型慢性阻塞性肺疾病急性加重期的疗效观察。
Chin J Integr Med. 2010 Apr;16(2):131-7. doi: 10.1007/s11655-010-0131-y. Epub 2010 May 16.
10
Effects of acetylcysteine on micro-inflammation and pulmonary ventilation in chronic obstructive pulmonary disease exacerbation.乙酰半胱氨酸对慢性阻塞性肺疾病急性加重期微炎症及肺通气的影响
World J Clin Cases. 2024 Jun 26;12(18):3482-3490. doi: 10.12998/wjcc.v12.i18.3482.

引用本文的文献

1
Retracted: Analyzing the Treatment of Patients with Acute Exacerbation of COPD with the Aid of Intelligent Diagnosis Method.撤回:借助智能诊断方法分析慢性阻塞性肺疾病急性加重患者的治疗
J Healthc Eng. 2023 Jul 26;2023:9759764. doi: 10.1155/2023/9759764. eCollection 2023.

本文引用的文献

1
Developing a patient-driven chronic obstructive pulmonary disease (COPD) research agenda in the U.S.在美国制定以患者为导向的慢性阻塞性肺疾病(COPD)研究议程
J Patient Rep Outcomes. 2021 Dec 4;5(1):126. doi: 10.1186/s41687-021-00399-7.
2
Use of a Digital Chronic Obstructive Pulmonary Disease Respiratory Tracker in a Primary Care Setting: A Feasibility Study.在基层医疗环境中使用数字慢性阻塞性肺疾病呼吸追踪器:一项可行性研究。
Pulm Ther. 2021 Dec;7(2):533-547. doi: 10.1007/s41030-021-00168-3. Epub 2021 Aug 31.
3
Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective.
用于哮喘或慢性阻塞性肺疾病的数字吸入器:科学视角
Pulm Ther. 2021 Dec;7(2):345-376. doi: 10.1007/s41030-021-00167-4. Epub 2021 Aug 11.
4
Budesonide/Glycopyrronium/Formoterol: A Review in COPD.布地奈德/格隆溴铵/福莫特罗:慢性阻塞性肺疾病综述
Drugs. 2021 Aug;81(12):1411-1422. doi: 10.1007/s40265-021-01562-6. Epub 2021 Aug 3.
5
Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重管理中的未满足需求。
Intern Emerg Med. 2021 Apr;16(3):559-569. doi: 10.1007/s11739-020-02612-9. Epub 2021 Feb 22.
6
Differential diagnosis of asthma and restrictive respiratory diseases by combining forced oscillation measurements, machine learning and neuro-fuzzy classifiers.通过结合强迫振荡测量、机器学习和神经模糊分类器对哮喘和限制性呼吸疾病进行鉴别诊断。
Med Biol Eng Comput. 2020 Oct;58(10):2455-2473. doi: 10.1007/s11517-020-02240-7. Epub 2020 Aug 10.
7
Artificial intelligence and machine learning in respiratory medicine.人工智能和机器学习在呼吸医学中的应用。
Expert Rev Respir Med. 2020 Jun;14(6):559-564. doi: 10.1080/17476348.2020.1743181. Epub 2020 Mar 17.
8
Coverage of ethics within the artificial intelligence and machine learning academic literature: The case of disabled people.人工智能和机器学习学术文献中的伦理问题研究:以残疾人为例。
Assist Technol. 2021 May 4;33(3):129-135. doi: 10.1080/10400435.2019.1593259. Epub 2019 Apr 17.
9
Underdiagnosis and Overdiagnosis of Asthma.哮喘的漏诊和过度诊断。
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1012-1020. doi: 10.1164/rccm.201804-0682CI.
10
Multichannel lung sound analysis for asthma detection.多通道肺音分析用于哮喘检测。
Comput Methods Programs Biomed. 2018 Jun;159:111-123. doi: 10.1016/j.cmpb.2018.03.002. Epub 2018 Mar 9.